Oral n-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial

Category Primary study
JournalArthritis & Rheumatism
Year 2010
This article has no abstract
Epistemonikos ID: 183ccffa10804c1ff5d1f86d5ac4f0dc3a9be776
First added on: Jan 15, 2015